Inventors: S Murugesan

The System initiative aims to develop a cutting-edge approach by leveraging systems biology in conjunction with stem cell technology to create a multi-tissue panel for fast and efficient drug screening, specifically focusing on potential COVID-19 treatments. This innovative platform seeks to expedite the process of identifying and testing various drug candidates to combat the global pandemic, offering a more comprehensive and versatile solution for evaluating treatment options. By utilizing advanced scientific methods and technology, the initiative forefronts the quest for effective therapies while emphasizing the importance of precision medicine in addressing public health challenges. (Pharmacy)